| Inflation took another jab at the bull market this week. The Dow Jones Industrial Average lost 600 points on Wednesday after a report showed consumer goods prices surged 4.2% in April, the highest spike since 2008. But investors saw an opportunity to “buy the dip,” and stocks regained a chunk of those losses to close out the week. It looks like the bull market will charge on. Speaking of dips, the Money & Markets team is targeting one segment of the market in particular: biotech. Chief investment strategist Adam O’Dell is not worried about the recent pullback in biotech stocks. In fact, he sees this as an open door for investors like you to get into the innovative field. Pro tip: For more on the future of biotech, check out the latest edition of The Bull & The Bear. Tomorrow, Adam will show you how the “size” factor of his proprietary Green Zone Ratings system for stocks helped one biotech small-cap grow into a healthy $4.5 billion mid-cap in only one year. And it’s not done growing yet! For now, here are some highlights on biotech and more from the last week on Money & Markets: - Adam isn’t the only biotech bull we have around here. Research analyst Matt Clark is right there with him, and he found a small-cap play within the industry. It rates well on Green Zone Ratings and has massive growth potential. Click here to find out more about this “Strong Bullish” stock.
- President Biden made waves with his recent capital gains tax proposal. You might be worried that a tax hike of this magnitude will scare big money out of markets. Adam walks you through Biden’s proposal and what it means for smaller investors like us, here.
- Green Zone Fortunes co-editor Charles Sizemore is back with another dividend stock to bolster your retirement portfolio. This American staple almost doubled its share price since the COVID-19 crash, and it’s poised for a steady climb higher, all while paying a competitive yield. Read more here.
Check out Matt’s Money & Markets Week Ahead below so you can prepare for Monday’s opening bell. Suggested Stories: Biotech’s 30% Dip: Your Entry Point Into a Future Top Trend Uncharted Inflation Territory: Wild Data, Price Scares and Your Money
| Most Americans did not. That's why I've put together an emergency briefing detailing five simple steps you can take to protect your portfolio and your family. We're already four months into his presidency so you don't have much more time prepare. | |
Week Ahead
Squarespace is launching its initial public offering this week. And it's bringing something unique to the IPO table. And I examine Target Corp.’s (NYSE: TGT) quarterly projections as retail earnings take center stage. We’ll also see how existing home sales performed in April. Check it out in my latest Money & Markets Week Ahead. Suggested Stories: A Bitcoin Nest Egg: Should Your IRA Meddle in Crypto? Tilray Stock Is Down — Here’s Why
| There's an important message that's lost on anyone listening to the mainstream narrative right now. But serious signs of trouble are already starting to appear. And the long-term effects will be devastating. Find out in this new video what's really going on. | |
| 
1971: In the U.S., the price for a 1-ounce First-Class stamp increased from 6 to 8 cents. | |
Privacy Policy
The Money & Markets, P.O. Box 8378, Delray Beach, FL 33482.
To ensure that you receive future issues of Money & Markets, please add info@mb.moneyandmarkets.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance.
The mailbox associated with this email address is not monitored, so please do not reply. Your feedback is very important to us so if you would like to contact us with a question or comment, please click here: https://moneyandmarkets.com/contact-us/
Legal Notice: This work is based on what we've learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It's your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Certain investments carry large potential rewards but also large potential risk. Don't trade in these markets with money you can't afford to lose. Money & Markets expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, Money & Markets, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast or 72 hours after a publication only circulated through the mail.
(c) 2021 Money & Markets. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Money & Markets. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 800-684-8471)
Remove your email from this list: Click here to Unsubscribe | | | 
Tidak ada komentar:
Posting Komentar